Biontech: Mainz biotech company starts mass tests with Covid-19 vaccine

IThe Mainz biotech company Biontech is at the forefront in the global race for a vaccine against Covid-19. In April, the company received official approval to vaccinate people for the first time in Germany against the lung disease caused by the novel corona virus. The first results from these tests are now available.

These are obviously so promising that Biontech and the US company Pfizer, with which the Mainz team has teamed up for the human project, now want to take the next step:

.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.